Creo Medical Group
CREO · AIM · Health Care · mcap £46m · 10.5p
Financials · LTM to 30 Jun 26
Source: results 30 Sep 26 ↗
Going-concern uncertainty
- Revenue
- £6.0m
- Operating profit
- −£17.8m
- Net income
- £5.3m
- Free cash flow
- −£23.0m
- Net cash
- £6.6m
- Market cap
- £47.2m
- EV / EBIT
- –
- FCF yield
- −48.8%
- Price / book
- 1.0×
Latest half-year · H1 26 vs H1 25
results 30 Sep 26 ↗
- Cash from operations
- −£10.7m prior −£8.0m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue | – | 6.0 | 4.0 |
| Gross profit | – | 2.4 | 1.9 |
| Adjusted EBITDA | (13.0) | (14.8) | – |
| Operating profit | – | (17.8) | (28.8) |
| Share-based payments | – | 1.4 | 1.5 |
| Finance costs | – | (0.3) | (0.4) |
| Profit before tax | – | (17.5) | (29.0) |
| Tax | – | 0.0 | 1.2 |
| Net income (owners) | – | 5.3 | (28.7) |
| Discontinued operations | (4.2) | 22.8 | (0.9) |
| EPS basic | – | 1.0p | (8.0p) |
| EPS diluted | – | 1.0p | (8.0p) |
| Latest Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Other intangibles | 1.6 | 1.3 | – |
| Property, plant & equipment | 3.0 | 3.4 | 5.9 |
| Associates & JVs | – | 30.9 | 0.0 |
| Inventories | 1.9 | 2.5 | 2.7 |
| Trade receivables | 8.9 | 5.6 | 2.0 |
| Cash | 7.4 | 12.4 | 8.7 |
| Total assets | 56.8 | 59.1 | 65.0 |
| Trade payables | 4.7 | 4.9 | 3.9 |
| Borrowings, current | – | 2.3 | 2.4 |
| Borrowings, non-current | 0.8 | 1.8 | 2.0 |
| Total liabilities | 8.6 | 9.1 | 22.6 |
| Total equity | 48.2 | 50.0 | 42.4 |
| H1 26 | H2 25 | H1 25 | H2 24 | |
|---|---|---|---|---|
| Other intangibles | 1.6 | 1.3 | 0.7 | – |
| Property, plant & equipment | 3.0 | 3.4 | 3.6 | 5.9 |
| Associates & JVs | – | 30.9 | – | 0.0 |
| Inventories | 1.9 | 2.5 | 3.2 | 2.7 |
| Trade receivables | 8.9 | 5.6 | 3.4 | 2.0 |
| Cash | 7.4 | 12.4 | 20.5 | 8.7 |
| Total assets | 56.8 | 59.1 | 68.8 | 65.0 |
| Trade payables | 4.7 | 4.9 | 3.6 | 3.9 |
| Borrowings, current | – | 2.3 | – | 2.4 |
| Borrowings, non-current | 0.8 | 1.8 | 1.9 | 2.0 |
| Total liabilities | 8.6 | 9.1 | 7.9 | 22.6 |
| Total equity | 48.2 | 50.0 | 60.9 | 42.4 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.